Deanne L. August, PhD: No financial relationships to disclose
Device completion and failure rates, clinical characteristics, and the frequency of neonatal vascular access device complications are rarely reported within the scientific literature. There are similar disparities for neonatal specific data within Australian national or facility reporting structures. Thus, vascular access device selection and management choices are determined by individual clinicians or local policies. Historically, Australian Neonatal units inconsistently consult or collaborate with specialised vascular access teams; therefore, slowing practice improvements or innovations that might be undertaken in older populations (e.g. reporting of first time insertion success, ultra sound guided insertion, etc). While neonates are similar to paediatrics, the assessment and identification of vascular access complications, particularly skin complications, is additionally challenging due to the unique nature of neonatal skin. This presentation cover a program of work undertaken in Queensland Australia by experts in neonatal care, neonatal skin assessment and vascular access research.
Learning Objectives:
Define types of vascular access devices used in neonatal care facilities, and expected timeframe for use
Describe vascular access devices utilised in observational study and related complications
Discuss the benefits and challenges to implementing a planning process for PIV insertion for neonates
Describe neonates who required re-insertion of PIVs during hospitalisation and clinical implications for there patients
Demonstrate the challenges of balancing effective vascular access performance with in skin health, and preventing complications
